|
Randomized Controlled Trial
Citations 31-40 of 115 total displayed.
|
Past content
(since May 1999):
|
- Clinical Trials
Stability of Visual Acuity Improvement Following Discontinuation of Amblyopia Treatment in Children Aged 7 to 12 Years
- Pediatric Eye Disease Investigator Group
Arch Ophthalmol 2007; 125: 655-659.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Prophylaxis of Acute Posttraumatic Bacterial Endophthalmitis: A Multicenter, Randomized Clinical Trial of Intraocular Antibiotic Injection, Report 2
- Masoud Soheilian; Nasrin Rafati; Mohammad-Reza Mohebbi; Shahin Yazdani; Houshang Faghihi Habibabadi; Mostafa Feghhi; Hossein A. Shahriary; Jamil Eslamipour; Niloofar Piri; Gholam A. Peyman; for the Traumatic Endophthalmitis Trial (TET) Research Group
Arch Ophthalmol 2007; 125: 460-465.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Randomized Controlled Study of an Intravitreous Dexamethasone Drug Delivery System in Patients With Persistent Macular Edema
- Baruch D. Kuppermann; Mark S. Blumenkranz; Julia A. Haller; George A. Williams; David V. Weinberg; Connie Chou; Scott M. Whitcup; for the Dexamethasone DDS Phase II Study Group
Arch Ophthalmol 2007; 125: 309-317.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Effect of Ruboxistaurin in Patients With Diabetic Macular Edema: Thirty-Month Results of the Randomized PKC-DMES Clinical Trial
- The PKC-DMES Study Group
Arch Ophthalmol 2007; 125: 318-324.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Internal Limiting Membrane Peeling With Indocyanine Green or Trypan Blue in Macular Hole Surgery: A Randomized Trial
- Julia Beutel; Gerlinde Dahmen; Andreas Ziegler; Hans Hoerauf
Arch Ophthalmol 2007; 125: 326-332.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Beta Carotene Supplementation and Age-Related Maculopathy in a Randomized Trial of US Physicians
- William G. Christen; JoAnn E. Manson; Robert J. Glynn; J. Michael Gaziano; Emily Y. Chew; Julie E. Buring; Charles H. Hennekens
Arch Ophthalmol 2007; 125: 333-339.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: V. Twelve-Year Mortality Rates and Prognostic Factors: COMS Report No. 28
- Collaborative Ocular Melanoma Study (COMS) Group
Arch Ophthalmol 2006; 124: 1684-1693.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: Year 1 Results of the FOCUS Study
- Jeffrey S. Heier; David S. Boyer; Thomas A. Ciulla; Philip J. Ferrone; J. Michael Jumper; Ronald C. Gentile; Debbi Kotlovker; Carol Y. Chung; Robert Y. Kim; for the FOCUS Study Group
Arch Ophthalmol 2006; 124: 1532-1542.
[Abstract]
[Full text]
[PDF]
- Controversies
Using a Drug Before the Risks and Benefits Are Known From a Phase 3 Clinical Trial: Thoughts on Compassion
- Joan W. Miller
Arch Ophthalmol 2006; 124: 1029-1031.
[Extract]
[Full text]
[PDF]
- Controversies
Uncertain Compassion in Using a Drug Before the Risks and Benefits Are Known
- Raja Narayanan; Baruch D. Kuppermann
Arch Ophthalmol 2006; 124: 1032-1034.
[Extract]
[Full text]
[PDF]
|
|
